(Q42984780)

English

An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C.

scientific article published on 24 October 2008

Statements

An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C. (English)
Y Benhamou
E M Yoshida
K D Kaita
S Zeuzem
M Torbenson
E Pulkstenis
G M Subramanian
J G McHutchison
24 October 2008
178-186

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit